PortfoliosLab logoPortfoliosLab logo
SKYE vs. WOLF
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SKYE vs. WOLF - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Skye Bioscience, Inc (SKYE) and Wolfspeed, Inc. (WOLF). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SKYE achieves a 2.71% return, which is significantly lower than WOLF's 218.32% return.


SKYE

1D
5.02%
1M
-10.75%
YTD
2.71%
6M
-36.36%
1Y
-68.31%
3Y*
-41.13%
5Y*
-54.71%
10Y*
-40.24%

WOLF

1D
0.65%
1M
18.93%
YTD
218.32%
6M
141.90%
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SKYE vs. WOLF - Yearly Performance Comparison


2026 (YTD)2025
SKYE
Skye Bioscience, Inc
2.71%-80.68%
WOLF
Wolfspeed, Inc.
218.32%-21.22%

Correlation

The correlation between SKYE and WOLF is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (All Time)
Calculated using the full available price history since Sep 30, 2025

0.17

Fundamentals

Market Cap

SKYE:

$30.55M

WOLF:

$21.77B

EPS

SKYE:

-$1.45

WOLF:

-$11.53

PB Ratio

SKYE:

3.39

WOLF:

21.31

Total Revenue (TTM)

SKYE:

$0.00

WOLF:

$712.50M

Gross Profit (TTM)

SKYE:

-$180.01K

WOLF:

-$208.10M

EBITDA (TTM)

SKYE:

$10.92M

WOLF:

-$1.26B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SKYE vs. WOLF — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SKYE
SKYE Risk / Return Rank: 1919
Overall Rank
SKYE Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
SKYE Sortino Ratio Rank: 2222
Sortino Ratio Rank
SKYE Omega Ratio Rank: 2121
Omega Ratio Rank
SKYE Calmar Ratio Rank: 1212
Calmar Ratio Rank
SKYE Martin Ratio Rank: 2121
Martin Ratio Rank

WOLF
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SKYE vs. WOLF - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Skye Bioscience, Inc (SKYE) and Wolfspeed, Inc. (WOLF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SKYEWOLFDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

0.94

Calmar ratioReturn relative to maximum drawdown

-0.78

Martin ratioReturn relative to average drawdown

-1.04

SKYE vs. WOLF - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


SKYEWOLFDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.59

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.42

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.29

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.36

2.34

-2.70

Drawdowns

SKYE vs. WOLF - Drawdown Comparison

The maximum SKYE drawdown since its inception was -99.96%, which is greater than WOLF's maximum drawdown of -58.22%. Use the drawdown chart below to compare losses from any high point for SKYE and WOLF.


Loading charts...

Drawdown Indicators


SKYEWOLFDifference

Max Drawdown

Largest peak-to-trough decline

-99.96%

-58.22%

-41.74%

Max Drawdown (1Y)

Largest decline over 1 year

-87.85%

Max Drawdown (3Y)

Largest decline over 3 years

-96.79%

Max Drawdown (5Y)

Largest decline over 5 years

-98.66%

Max Drawdown (10Y)

Largest decline over 10 years

-99.83%

Current Drawdown

Current decline from peak

-99.94%

-24.60%

-75.34%

Average Drawdown

Average peak-to-trough decline

-94.95%

-34.87%

-60.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

65.76%

Volatility

SKYE vs. WOLF - Volatility Comparison


Loading charts...

Volatility by Period


SKYEWOLFDifference

Volatility (1M)

Calculated over the trailing 1-month period

28.64%

Volatility (6M)

Calculated over the trailing 6-month period

63.38%

Volatility (1Y)

Calculated over the trailing 1-year period

115.33%

120.69%

-5.36%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

130.81%

120.69%

+10.12%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

137.31%

120.69%

+16.62%

Dividends

SKYE vs. WOLF - Dividend Comparison

Neither SKYE nor WOLF has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

SKYE vs. WOLF - Financials Comparison

This section allows you to compare key financial metrics between Skye Bioscience, Inc and Wolfspeed, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M202220232024202520260
150.20M
(SKYE) Total Revenue
(WOLF) Total Revenue
Values in USD except per share items

Frequently Asked Questions


SKYE and WOLF have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for SKYE and WOLF

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer